Thursday, May 21, 2020

ICMR Clinical Trials on BCG Vaccine to Treat COVID-19 Patients

Can BCG vaccine treat coronavirus patients? Till now many things were happening about this. But now research has started. For this, the vaccine is being trialed. 
ICMR is conducting clinical trials to investigate the efficacy of the TB vaccine against COVID-19.
BCG Vaccine
IBCG Vaccine and COVID-19 

ICMR Clinical Trials Begins on BCG Vaccine to Treat COVID-19 Patients

The Indian Council of Medical Research is conducting clinical trials to investigate the efficacy of the Tuberculosis (TB) vaccine against coronavirus disease.

ICMR is focusing on India's vaccine potential in reducing the deaths of COVID-19 infected patients. 
Trials examining the efficacy of the BCG vaccine in COVID-19 patients will be conducted in association with the National Institute for Research in Tuberculosis [Formerly Tuberculosis Research Centre (TRC)].

According to researchers at the Biomedical Sciences of the New York Institute of Technology (NYIT), the incidence of COVID-19 is relatively low in countries with a BCG vaccine program.

BCG Vaccine

Bacillus Calmette–GuĂ©rin vaccine (BCG vaccine) is a vaccine primarily used against tuberculosis.
The BCG vaccine is a needle given to children who are at greater risk of TB. The BCG vaccine helps your child's immune system fight the germs that cause tuberculosis and prevents it from causing severe TB disease.

The BCG vaccine uses a live attenuated strain of Mycobacterium Bovis. This means that the power of the germ is artificially disabled.

The trial has begun to find out how effective the BCG vaccine is in preventing the coronavirus.
ICMR will examine the effect of BCG by applying vaccines to the people coming in contact with the patients of Corona.


National BCG Vaccination Policy

India is currently following the national BCG vaccination policy. According to the National Family Health Survey (NFHS), approximately 91.9% of children in the age group of 12 to 23 months are receiving the vaccine. The survey also said that India has the capacity to produce 2,800 lakh BCG vaccines in a year.

No comments:

Post a Comment